Product
Universal Donor Natural Killer Cells
1 clinical trial
1 indication
Indication
Acute Myeloid LeukemiaClinical trial
Killer Cells Against Relapsed/Refractory Myeloid Acute Leukemia (KARMA): A Clinical Trial Evaluating the Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Treatment of Young Adults With Relapsed/Refractory Acute Myeloid LeukemiaStatus: Recruiting, Estimated PCD: 2027-02-01